Checkpoint Therapeutics, Inc. (CKPT) financial statements (2020 and earlier)

Company profile

Business Address 2 GANSEVOORT STREET
NEW YORK, NY 10014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13221935
Cash and cash equivalents13221935
Other current assets0201
Other undisclosed current assets1120
Total current assets:14252136
Noncurrent Assets
TOTAL ASSETS:14252136
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:71263
Accounts payable41042
Accrued liabilities0000
Employee-related liabilities0000
Other undisclosed accounts payable and accrued liabilities3210
Due to related parties1110
Total current liabilities:81364
Noncurrent Liabilities
Total liabilities:81364
Stockholders' equity
Stockholders' equity attributable to parent, including:6121532
Common stock0000
Common stock, value, subscriptions 224
Additional paid in capital1181057265
Accumulated deficit(111)(95)(59)(36)
Other undisclosed stockholders' equity attributable to parent0000
Total stockholders' equity:6121532
TOTAL LIABILITIES AND EQUITY:14252136

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Revenue, net23
Revenue from related parties54
Gross profit:5423
Operating expenses(33)(40)(25)(25)
Operating loss:(28)(37)(23)(22)
Nonoperating income (expense)000(0)
Investment income, nonoperating0000
Other nonoperating income 0  
Interest and debt expense   (0)
Net loss:(28)(36)(23)(23)
Other undisclosed net income attributable to parent   0
Net loss available to common stockholders, diluted:(28)(36)(23)(22)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Net loss:(28)(36)(23)(23)
Comprehensive loss, net of tax, attributable to parent:(28)(36)(23)(23)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: